Spring Steelman Symposium: Defeating RAS, the Beating Heart of Cancer

Honoring Channing J. Der, PhD

Sarah G. Kenan Distinguished Professor
Department of Pharmacology
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill

Event Description: Dr. Channing Der has made seminal contributions to the RAS field beginning with his discovery of activated RAS oncogenes in human cancers. This half-day symposium will highlight recent advances in RAS signaling and targeted therapeutics.

Invited keynote speakers include Andrew J. Aguirre MD, PhD (Harvard Medical School / Dana-Farber Cancer Institute), David S. Hong, MD (MD Anderson Cancer Center), and Mallika Singh, PhD (Revolution Medicines).

Additionally, Der Lab alumni talks will be delivered by Tikvah K. Hayes, PhD (University of California, Los Angeles), Kirsten L. Bryant, PhD (University of North Carolina at Chapel Hill), and Clint A. Stalnecker, PhD (University of North Carolina at Chapel Hill).

Channing Der, PhD will deliver the Steelman Distinguished Lectureship at the conclusion of the symposium. 

Detailed agenda to follow in early 2026.

Location: TBD

Host: Steelman Committee (Kirsten Bryant, Adrienne Cox, Kevin Pruitt, Mike Emanuele, and John Morris)